Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits.
Support Care Cancer
; 25(1): 237-244, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27619389
Key words
Search on Google
Database:
MEDLINE
Main subject:
Oncologists
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article